SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-18-320941
Filing Date
2018-11-07
Accepted
2018-11-07 16:19:09
Documents
62
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q d640484d10q.htm 10-Q 583998
2 EX-31.1 d640484dex311.htm EX-31.1 11111
3 EX-31.2 d640484dex312.htm EX-31.2 11444
4 EX-32.1 d640484dex321.htm EX-32.1 6073
  Complete submission text file 0001193125-18-320941.txt   4390457

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT hrtx-20180930.xml EX-101.INS 1084195
6 XBRL TAXONOMY EXTENSION SCHEMA hrtx-20180930.xsd EX-101.SCH 44316
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE hrtx-20180930_cal.xml EX-101.CAL 32981
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE hrtx-20180930_def.xml EX-101.DEF 302501
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE hrtx-20180930_lab.xml EX-101.LAB 254826
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE hrtx-20180930_pre.xml EX-101.PRE 321690
Mailing Address 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121
Business Address 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121 6503662626
HERON THERAPEUTICS, INC. /DE/ (Filer) CIK: 0000818033 (see all company filings)

IRS No.: 942875566 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33221 | Film No.: 181166602
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1